79 related articles for article (PubMed ID: 1644865)
1. Teratocarcinoma F9 cells induced to differentiate with sodium butyrate produce both tissue-type and urokinase-type plasminogen activators.
Takeda M; Kosaka M; Nishina Y; Sawada K; Matsumoto K; Nishimune Y
J Cell Biochem; 1992 Jul; 49(3):284-9. PubMed ID: 1644865
[TBL] [Abstract][Full Text] [Related]
2. The induction of jun genes during the reversible changes induced with sodium butyrate on the differentiation of F9 cells.
Nishina Y; Sumi T; Iwai SA; Kosaka M; Nishimune Y
Exp Cell Res; 1993 Oct; 208(2):492-7. PubMed ID: 8375477
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.
Gross JL; Behrens DL; Mullins DE; Kornblith PL; Dexter DL
Cancer Res; 1988 Jan; 48(2):291-6. PubMed ID: 3121170
[TBL] [Abstract][Full Text] [Related]
4. Ultraviolet irradiation, although it activates the transcription factor AP-1 in F9 teratocarcinoma stem cells, does not induce the full complement of differentiation-associated genes.
Auer HP; König H; Litfin M; Stein B; Rahmsdorf HJ
Exp Cell Res; 1994 Sep; 214(1):131-8. PubMed ID: 7521841
[TBL] [Abstract][Full Text] [Related]
5. Different response to retinoic acid of two teratocarcinoma cell lines.
Wan YJ; Wang L; Wu TC
Exp Cell Res; 1995 Aug; 219(2):392-8. PubMed ID: 7543852
[TBL] [Abstract][Full Text] [Related]
6. Production, purification and characterization of the plasminogen activator in teratocarcinoma stem cells induced with sodium butyrate.
Ichikawa N; Miyashita T; Nishimune Y; Matsushiro A
Biken J; 1984 Dec; 27(4):143-51. PubMed ID: 6443174
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes.
Seki T; Miyasu T; Noguchi T; Hamasaki A; Sasaki R; Ozawa Y; Okukita K; Declerck PJ; Ariga T
J Cell Physiol; 2001 Oct; 189(1):72-8. PubMed ID: 11573206
[TBL] [Abstract][Full Text] [Related]
8. Retinoids increase urokinase-type plasminogen activator production by human retinal pigment epithelial cells in culture.
Immonen I; Sirén V; Stephens RW; Liesto K; Vaheri A
Invest Ophthalmol Vis Sci; 1993 May; 34(6):2062-7. PubMed ID: 8491555
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator expression in F9 teratocarcinoma embryoid bodies and their endoderm derivatives.
Sabbag KR; Casanova JE; Grabel LB
Development; 1989 May; 106(1):195-201. PubMed ID: 2516796
[TBL] [Abstract][Full Text] [Related]
10. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
11. Cyclic adenosine monophosphate-mediated induction of F9 teratocarcinoma differentiation in the absence of retinoic acid.
Goldstein B; Rogelj S; Siegel S; Farmer SR; Niles RM
J Cell Physiol; 1990 May; 143(2):205-12. PubMed ID: 1692026
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid priming potentiates the induction of urokinase-type plasminogen activator by cyclic adenosine monophosphate in mouse mammary carcinoma cells.
Mira-y-Lopez R
J Cell Physiol; 1991 Apr; 147(1):46-54. PubMed ID: 1645361
[TBL] [Abstract][Full Text] [Related]
13. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO
Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665
[TBL] [Abstract][Full Text] [Related]
14. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
McGowen R; Biliran H; Sager R; Sheng S
Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
[TBL] [Abstract][Full Text] [Related]
15. The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells.
Tienari J; Alanko T; Lehtonen E; Saksela O
Cell Regul; 1991 Apr; 2(4):285-97. PubMed ID: 1905574
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
[TBL] [Abstract][Full Text] [Related]
17. Mouse cellular retinoic acid binding protein: cloning, complementary DNA sequence, and messenger RNA expression during the retinoic acid-induced differentiation of F9 wild type and RA-3-10 mutant teratocarcinoma cells.
Stoner CM; Gudas LJ
Cancer Res; 1989 Mar; 49(6):1497-504. PubMed ID: 2538228
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
Waghray A; Webber MM
Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
[TBL] [Abstract][Full Text] [Related]
19. Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases.
Kondo K; Tsuneizumi K; Watanabe T; Oishi M
Cancer Res; 1991 Oct; 51(19):5398-404. PubMed ID: 1680548
[TBL] [Abstract][Full Text] [Related]
20. Changes in Hox1.6, c-jun, and Oct-3 gene expressions are associated with teratocarcinoma F9 cell differentiation in three different ways of induction.
Iwai SA; Kosaka M; Nishina Y; Sumi T; Sakuda M; Nishimune Y
Exp Cell Res; 1993 Mar; 205(1):39-43. PubMed ID: 8453995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
